Back

Attainment of the low-density lipoprotein cholesterol treatment target and prognosis of heterozygous familial hypercholesterolemia

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Risk factors and prevention: lipids (5) Lipids ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Hayato Tada

Kanazawa University, Kanazawa (Japan)

8 More presentations in this session

Presentation thumbnail
Early diagnosis and treatments in childhood are associated with better prognosis in patients with familial hypercholesterolemia
Doctor H. Tada (Kanazawa, JP)
Abstract Slides Video
Presentation thumbnail
L-shaped association of lipoprotein(a) on long-term bleeding risk in patients with coronary heart disease: insight from a multicenter cohort in Asia
Doctor P. Wang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Survey on lipid management in cardiovascular primary prevention: do physicians follow the guidelines?
Professor M. Alami (Casablanca, MA)
Abstract Slides Video
Presentation thumbnail
Remnant cholesterol predicts major cardiovascular events in cardiovascular disease patients with NAFLD
Doctor B. Larcher (Feldkirch, AT)
Abstract Slides Video
Presentation thumbnail
Remnant cholesterol in atherosclerotic cardiovascular disease: a systematic review and meta-analysis
Doctor D. Delialis (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Risk factors and prevention: lipids (5)

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Congress Presentation
Lipid control in cardiovascular patients
thumbnail
Congress Presentation
Lipidomics to fine-tune cardiovascular risk prediction and personalised treatment

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources